Eagon PK, Elm MS, Hunter DS, et al. Medicinal herbs: modulation of estrogen action. Era of Hope Mtg, Dept Defense; Breast Cancer Res Prog, Atlanta, GA 2000;Jun 8-11.

Cahill DJ, Fox R, Wardle PG, et al. Multiple follicular development associated with herbal medicine. Hum Reprod 1994;9:1469-70. View abstract.

Du Mee C. Vitex agnus castus. Aust J Med Herb 1993;5:63-5.

Brown D. Vitex agnus castus clinical monograph. Qtrly Rev Natural Med 1994;2:111-21.

Wuttke W. Dopaminergic action of extracts of Agnus Castus. Forschende Komplementarmedizen 1996;3:329-30.

Jarry H, Leonhardt S., Gorkow C, Wuttke W. In vitro prolactin but not LH and FSH release is inhibited by compounds in extracts of Agnus Castus: direct evidence for a dopaminergic principle by the dopamine receptor assay. Exp Clin Endocrinol 1994;102:448-54. View abstract.

Merz P, Gorkow C, Schroder A, et al. The effects of a special Agnus castus extract (BP1095el) on prolactin secretion in healthy male subjects. Exp Clin Endocrinol Diabetes 1996;104:447-53. View abstract.

Schellenberg R. Treatment for the premenstrual syndrome with agnus castus fruit extract: prospective, randomised, placebo-controlled study. BMJ 2001;322:134-7. View abstract.

Lauritzen CH, Reuter HD, Repges R, et al. Treatment of premenstrual tension syndrome with Vitex agnus castus: Controlled-double blind versus pyridoxine. Phytomedicine 1997;4:183-9.

Gerhard II, Patek A, Monga B, et al. Mastodynon for female infertility. (abstract) Forsch Komplementarmed 1998;5:272-8. View abstract.

Berger D, Schaffner W, Schrader E, et al. Efficacy of Vitex agnus castus L. extract Ze 440 in patients with premenstrual syndrome (PMS). Arch Gynecol Obstet 2000;264:150-3. View abstract.

Loch EG, Selle H, Boblitz N. Treatment of premenstrual syndrome with a phytopharmaceutical formulation containing Vitex agnus castus. J Womens Health Gend Based Med 2000;9:315-20. View abstract.

Milewicz A, Gejdel E, Sworen H, et al. [Vitex agnus castus extract in the treatment of luteal phase defects due to latent hyperprolactinemia. Results of a randomized placebo-controlled double-blind study]. Arzneimittelforschung 1993;43:752-6.. View abstract.

Dixon-Shanies D, Shaikh N. Growth inhibition of human breast cancer cells by herbs and phytoestrogens. Oncol Rep 1999;6:1383-7.. View abstract.

Ohyama K, Akaike T, Hirobe C, Yamakawa T. Cytotoxicity and apoptotic inducibility of Vitex agnus-castus fruit extract in cultured human normal and cancer cells and effect on growth. Biol Pharm Bull 2003;26:10-18. View abstract.

Upton R, ed. Chaste Tree Fruit. American Herbal Pharmacopoeia and Therapeutic Compendium. Santa Cruz, CA; American Herbal Pharmacopoeia 2001:1-37.

Meier B, Berger D, Hoberg E, et al. Pharmacological activities of Vitex agnus-castus extracts in vitro. Phytomedicine 2000;7:373-81. View abstract.

Wuttke W, Jarry H, Christoffel V, et al. Chaste tree (Vitex agnus-castus)--pharmacology and clinical indications. Phytomedicine 2003;10:348-57. View abstract.

Atmaca M, Kumru S, Tezcan E. Fluoxetine versus Vitex agnus castus extract in the treatment of premenstrual dysphoric disorder. Hum Psychopharmacol 2003;18:191-5.. View abstract.

Ono M, Yanaka T, Yamamoto M, et al. New diterpenes and norditerpenes from the fruits of Vitex rotundifolia. J Nat Prod 2002;65:537-41. View abstract.

Okuyama E, Fujimori S, Yamazaki M, Deyama T. Pharmacologically active components of viticis fructus (Vitex rotundifolia). II. The components having analgesic effects. Chem Pharm Bull (Tokyo) 1998;46:655-62. View abstract.

Shin TY, Kim SH, Lim JP, et al. Effect of Vitex rotundifolia on immediate-type allergic reaction. J Ethnopharmacol 2000;72:443-50. View abstract.

Hossain MM, Paul N, Sohrab MH, et al. Antibacterial activity of Vitex trifolia. Fitoterapia 2001;72:695-7. View abstract.

Daniele C, Thompson Coon J, Pittler MH, Ernst E. Vitex agnus castus: a systematic review of adverse events. Drug Saf 2005;28:319-32.. View abstract.

Turner S, Mills S. A double-blind clinical trial on a herbal remedy for premenstrual syndrome: a case study. Complement Ther Med 1993;1:73-77.

Halaska M, Beles P, Gorkow C, Sieder C. Treatment of cyclical mastalgia with a solution containing a Vitex agnus castus extract: results of a placebo-controlled double-blind study. Breast 1999;8:175-81. View abstract.

Mehlhorn H, Schmahl G, Schmidt J. Extract of the seeds of the plant Vitex agnus castus proven to be highly efficacious as a repellent against ticks, fleas, mosquitoes and biting flies. Parasitol Res 2005;95:363-5. View abstract.

Liu J, Burdette JE, Sun Y, et al. Isolation of linoleic acid as an estrogenic compound from the fruits of Vitex agnus-castus L. (chaste-berry). Phytomedicine 2004;11:18-23. View abstract.

Prilepskaya VN, Ledina AV, Tagiyeva AV, Revazova FS. Vitex agnus castus: Successful treatment of moderate to severe premenstrual syndrome. Maturitas 2006;55 Suppl 1:S55-63.

Rotem C, Kaplan B. Phyto-Female Complex for the relief of hot flushes, night sweats and quality of sleep: randomized, controlled, double-blind pilot study. Gynecol Endocrinol 2007;23:117-22. View abstract.

Mazaro-Costa, R., Andersen, M. L., Hachul, H., and Tufik, S. Medicinal plants as alternative treatments for female sexual dysfunction: utopian vision or possible treatment in climacteric women? J.Sex Med. 2010;7(11):3695-3714. View abstract.

Whelan, A. M., Jurgens, T. M., and Naylor, H. Herbs, vitamins and minerals in the treatment of premenstrual syndrome: a systematic review. Can.J.Clin.Pharmacol. 2009;16(3):e407-e429. View abstract.

Bergmann, J., Luft, B., Boehmann, S., Runnebaum, B., and Gerhard, I. [The efficacy of the complex medication Phyto-Hypophyson L in female, hormone-related sterility. A randomized, placebo-controlled clinical double-blind study]. Forsch Komplementarmed Klass Naturheilkd 2000;7(4):190-199. View abstract.

Lucks, B. C., Sorensen, J., and Veal, L. Vitexagnus-castus essential oil and menopausal balance: a self-care survey. Complement Ther Nurs.Midwifery 2002;8(3):148-154. View abstract.

Fugh-Berman, A. and Kronenberg, F. Complementary and alternative medicine (CAM) in reproductive-age women: a review of randomized controlled trials. Reprod Toxicol. 2003;17(2):137-152. View abstract.

Jarry, H., Spengler, B., Porzel, A., Schmidt, J., Wuttke, W., and Christoffel, V. Evidence for Estrogen Receptor beta-Selective Activity of Vitex agnus-castus and Isolated Flavones. Planta Med 2003;69(10):945-947. View abstract.

Westphal, L. M., Polan, M. L., Trant, A. S., and Mooney, S. B. A nutritional supplement for improving fertility in women: a pilot study. J Reprod Med. 2004;49(4):289-293. View abstract.

Mancho, P. and Edwards, Q. T. Chaste tree for premenstrual syndrome. An evolving therapy in the United States. Adv.Nurse Pract. 2005;13(5):43-4, 46. View abstract.

Newton, K. M., Reed, S. D., Grothaus, L., Ehrlich, K., Guiltinan, J., Ludman, E., and Lacroix, A. Z. The Herbal Alternatives for Menopause (HALT) Study: background and study design. Maturitas 10-16-2005;52(2):134-146. View abstract.

Dennehy, C. E. The use of herbs and dietary supplements in gynecology: an evidence-based review. J Midwifery Womens Health 2006;51(6):402-409. View abstract.

Ben-Arye, E., Oren, A., and Ben-Arie, A. [Herbal medicine in womens' life cycle]. Harefuah 2006;145(10):738-42, 782. View abstract.

Westphal, L. M., Polan, M. L., and Trant, A. S. Double-blind, placebo-controlled study of Fertilityblend: a nutritional supplement for improving fertility in women. Clin Exp.Obstet.Gynecol. 2006;33(4):205-208. View abstract.

Singleton, G. Premenstrual disorders in adolescent females-- integrative management. Aust.Fam.Physician 2007;36(8):629-630. View abstract.

Dugoua, J. J., Seely, D., Perri, D., Koren, G., and Mills, E. Safety and efficacy of chastetree (Vitex agnus-castus) during pregnancy and lactation. Can.J Clin Pharmacol. 2008;15(1):e74-e79. View abstract.

van Die, M. D., Burger, H. G., Bone, K. M., Cohen, M. M., and Teede, H. J. Hypericum perforatum with Vitex agnus-castus in menopausal symptoms: a randomized, controlled trial. Menopause. 2009;16(1):156-163. View abstract.

He, Z., Chen, R., Zhou, Y., Geng, L., Zhang, Z., Chen, S., Yao, Y., Lu, J., and Lin, S. Treatment for premenstrual syndrome with Vitex agnus castus: A prospective, randomized, multi-center placebo controlled study in China. Maturitas 5-20-2009;63(1):99-103. View abstract.

Doll, M. [The premenstrual syndrome: effectiveness of Vitex agnus castus]. Med.Monatsschr.Pharm. 2009;32(5):186-191. View abstract.

van Die, M. D., Bone, K. M., Burger, H. G., and Teede, H. J. Are we drawing the right conclusions from randomised placebo-controlled trials? A post-hoc analysis of data from a randomised controlled trial. BMC.Med.Res Methodol. 2009;9:41. View abstract.

van Die, M. D., Teede, H. J., Bone, K. M., Reece, J. E., and Burger, H. G. Predictors of placebo response in a randomized, controlled trial of phytotherapy in menopause. Menopause. 2009;16(4):792-796. View abstract.

van Die, M. D., Burger, H. G., Teede, H. J., and Bone, K. M. Vitex agnus-castus (Chaste-Tree/Berry) in the treatment of menopause-related complaints. J Altern.Complement Med. 2009;15(8):853-862. View abstract.

van Die, M. D., Bone, K. M., Burger, H. G., Reece, J. E., and Teede, H. J. Effects of a combination of Hypericum perforatum and Vitex agnus-castus on PMS-like symptoms in late-perimenopausal women: findings from a subpopulation analysis. J.Altern.Complement Med. 2009;15(9):1045-1048. View abstract.

Ma, L., Lin, S., Chen, R., and Wang, X. Treatment of moderate to severe premenstrual syndrome with Vitex agnus castus (BNO 1095) in Chinese women. Gynecol.Endocrinol. 2010;26(8):612-616. View abstract.

Ma, L., Lin, S., Chen, R., Zhang, Y., Chen, F., and Wang, X. Evaluating therapeutic effect in symptoms of moderate-to-severe premenstrual syndrome with Vitex agnus castus (BNO 1095) in Chinese women. Aust.N.Z.J Obstet.Gynaecol. 2010;50(2):189-193. View abstract.

Freeman, E. W. Therapeutic management of premenstrual syndrome. Expert.Opin.Pharmacother. 2010;11(17):2879-2889. View abstract.

Dante, G. and Facchinetti, F. Herbal treatments for alleviating premenstrual symptoms: a systematic review. J Psychosom.Obstet.Gynaecol. 2011;32(1):42-51. View abstract.

Ciotta, L., Pagano, I., Stracquadanio, M., Di, Leo S., Ando, A., and Formuso, C. [Psychic aspects of the premenstrual dysphoric disorders. New therapeutic strategies: our experience with Vitex agnus castus]. Minerva Ginecol. 2011;63(3):237-245. View abstract.

Zamani, M., Neghab, N., and Torabian, S. Therapeutic effect of Vitex agnus castus in patients with premenstrual syndrome. Acta Med.Iran 2012;50(2):101-106. View abstract.

Laakmann, E., Grajecki, D., Doege, K., zu, Eulenburg C., and Buhling, K. J. Efficacy of Cimicifuga racemosa, Hypericum perforatum and Agnus castus in the treatment of climacteric complaints: a systematic review. Gynecol.Endocrinol. 2012;28(9):703-709. View abstract.

Pearlstein, T. Psychotropic medications and other non-hormonal treatments for premenstrual disorders. Menopause.Int 2012;18(2):60-64. View abstract.

Lauritzen, C., Reuter, H. D., Repges, R., Bohnert, K. J., and Schmidt, U. Treatment of premenstrual tension syndrome with Vitex agnus castus controlled, double-blind study versus pyridoxine. Phytomedicine. 1997;4(3):183-189. View abstract.

Kubista, E., Muller, G., and Spona, J. [Treatment of mastopathies with cyclic mastodynia. Clinical results and hormonal profiles]. Rev Fr.Gynecol Obstet 1987;82(4):221-227. View abstract.

Schwalbe, E. [Treatment of mastodynia]. ZFA.(Stuttgart.) 8-10-1979;55(22):1239-1242. View abstract.

Opitz, G. and Liebl, A. [Conservative treatment of mastopathy with Mastodynon]. Ther Ggw. 1980;119(7):804-809. View abstract.

Sliutz, G., Speiser, P., Schultz, A. M., Spona, J., and Zeillinger, R. Agnus castus extracts inhibit prolactin secretion of rat pituitary cells. Horm.Metab Res 1993;25(5):253-255. View abstract.

Fikentscher, H. [Aetiology, diagnosis und therapy of mastopathy and mastodynia. Experiences of treatment with mastodynon (author's transl)]. Med Klin 8-26-1977;72(34):1327-1330. View abstract.

Halaska, M., Raus, K., Beles, P., Martan, A., and Paithner, K. G. [Treatment of cyclical mastodynia using an extract of Vitex agnus castus: results of a double-blind comparison with a placebo]. Ceska.Gynekol. 1998;63(5):388-392. View abstract.

Wuttke W, Splitt G, Gorkow C, and et al. Behandlung zyklusabhangiger brustschmerzen mit einem Agnus castus-haltigen arzneimittel [Treatment of cyclical mastalgia: Results of a randomized, placebo-controlled, double-blind study]. Geburtsh.u.Frauenheilk 1997;57:569-574.

Bleier W. Therapie von Zyklus- und Blutungsstorungen und weiteren endokrin bedingten Erkrankungen der Frau mit pflanzlichen Wirkstoffen. Zbl Gynakol 1959;81:701-709.

Winterhoff H, Gorkow C, and Behr B. Die Hemmung der Laktation bei Ratten als indirekter Beweis fur die Senkung von Prolaktin durch Agnus castus. Zeitschrift fur Phytotherapie 1991;12:175-179.

Feldmann HU, Albrecht M, Lamertz M, and et al. The treatment of corpus Luteum insufficiency and premenstrual syndrome. Experience in a multicenter study under clinical practice conditions. [in German]. Gyne 1990;11(12):421-425.

Propping D. Vitex agnus-castus: treatment of gynecological syndromes. [in German]. Therapeutikon 1991;5:581-585.

Probst V and Roth OA. On a plant extract with a hormone-like effects. Deutsch Medizin Zeitschrift 1954;35:1271-1274.

Schellenberg R, Schrader E, and Brattström A. Vitex agnus castus extrakt Ze440 bei pramenstruellem syndrom: ergebnisse einer RCT im vergleich mit plazebo bei 170 patientinnen. Abstracts Book - Symposium Phytopharmaka VII.Forschung und klinische anwendung, October 12-13 2001;

Turner S and Mills S. A double-blind clinical trial on a herbal remedy for premenstrual syndrome: a case study. Complementary Therapies in Medicine 1993;1(2):73-77.

Peters-Welte C and Albrecht M. [Menstrual abnormalities and PMS. Vitex agnus-castus in a study of application]. Therapiewoche Gynakologie 1994;7(1):49-52.

Pepeljnjak S, Antolic A, and Kustrak D. Antibacterial and antifungal activities of the Vitex agnus-castus L. extracts. Acta Pharmaceutica Zagreb 1996;46(3):201-206.

Mishurova SS. Essential oil in Vitex agnus astus L., its component composition and antimicrobial activity. Rastitel 'nye Resursy 1986;22(4):526-530.

Jarry H, Leonhardt S, Wuttke W, and et al. [Agnus castus as a dopaminergic active constituent in Mastodynon N]. Zeitschrift fur Phytotherapie 1991;12:77-82.

Bubenzer RH. Therapy with Agnus castus extract (Strotan

Prilepskaya, V. N., Ledina, A. V., Tagiyeva, A. V., and Revazova, F. S. Vitex agnus castus: Successful treatment of moderate to severe premenstrual syndrome. Maturitas 2006;55(Suppl 1):S55-63.

Dittmar FW. Premenstrual syndrome: treatment with a phytopharmaceutical [in German]. TW Gynakologie 1992;5(1):60-68.

Liebel H. Behandlung des prämenstruellen Syndromes. Agnus castus-haltige Kombinationsarzneimittel im Test. Therapiewoche Gynakol 1992;5:2-12.

Meyl C. Therapie des prämenstruellen syndroms. Vergleich einer kombinierten behandlung von mastodynon und vitamin E mit der vitamin E-monotherapie. Therapeutikon 1991;5(10):518-525.

Coeugniet E. Premenstrual syndrome and its treatment. Arztezeitchr Naturheilverf 1986;27:619-622.

Propping D, Katzorke T, and Belkien L. Diagnostik und therapie der gelbkorperschwache in der praxis. Therapiewoche 1988;38:2992-3001.

Göbel R. Results of the clinical evaluations of Danazol in benign breast disease compared with local treatment, gestagens, and bromocriptine. In: Baum M, George WD, and Hughes LE. Benign Breast Diseases. London: Roy Soc Med Int;1985.

Gregl A. Klinik und therapie der mastodynie. Med Welt 1985;36:242-246.

Fournier D and Grumbrecht C. Behandlung der mastopathie, mastodynie und des prämenstruellen syndroms. Verleich medikamentöser behandlung zu unbehandelten kontrollen. Therapiewoche 1987;37(5):430-434.

Fersizoglou NE. Hormonale und thermographische veränderungen unter konservativer therapie der mastophathie. Vergleich von danazol, tamoxifen, lisurid, lynesterenol und einem phytopharmakon. Dissertation 1989;

Krapfl E. Prospektiv randomisierte klinische thrapiestudie zum wirksamkeitsvergleich von Orgametril®, einem 19 nor-testosteron-derivat, versus Mastodynon®, agnus castus-haltigen alkoholischen pflanzenextrakt, bei schmerzhafter mastopathie. Dissertation 1988;

World Health Organization. Monographs on Selected Medicinal Plants. 2004;4

Halder R. Über die anwendungsmoglichkeiten von vitex agnus-castus L. in der frauenheilkunde unter besonderer berücksichtigung der blutungsstörungen. Dissertation 1957;

Roth OA. Zur therapie der gelbkörperinsuffizienz in der praxis. Med Klin 1956;51:1263-1265.

Mergner R. Zyklusstörungen: therapie mit einem vitex-agnus-castus-haltigen kombinationsarzneimittel. Der Kassenarzt 1992;7:51-60.

Kayser HW and Istanbulluoglu S. Vitex agnus castus. Hippokrates 1954;25:717-719.

Dinç T, Coskun F. Comparison of fructus agni casti and flurbiprofen in the treatment of cyclic mastalgia in premenopausal women. Ulus Cerrahi Derg. 2014 Mar 1;30(1):34-8 View abstract.

Eftekhari MH, Rostami ZH, Emami MJ, Tabatabaee HR. Effects of "vitex agnus castus" extract and magnesium supplementation, alone and in combination, on osteogenic and angiogenic factors and fracture healing in women with long bone fracture. J Res Med Sci. 2014 Jan;19(1):1-7. View abstract.

Momoeda M, Sasaki H, Tagashira E, Ogishima M, Takano Y, Ochiai K. Efficacy and safety of Vitex agnus-castus extract for treatment of premenstrual syndrome in Japanese patients: a prospective, open-label study. Adv Ther. 2014 Mar;31(3):362-73. View abstract.

Yavarikia P, Shahnazi M, Hadavand Mirzaie S, Javadzadeh Y, Lutfi R. Comparing the effect of mefenamic Acid and vitex agnus on intrauterine device induced bleeding. J Caring Sci. 2013 Aug 31;2(3):245-54. View abstract.

Artz MB. Vitex agnus-castus. In Herbal Products: Toxicology and Clinical Pharmacology, Second Edition. Ed. Tracy TS, Kingston RL. Humana Press Inc., Totowa, NJ: 2007.

Van Die MD, Burger HC, Teede HG, Bone KM. Vitex agnus castus extracts for female reproductive disorders: a systematic review of clinical trials. Planta Med 2013:79:562-575. View abstract.

Mirghafourvand M, Mohammad-Alizadeh-Charandabi S, Ahmadpour P, Javadzadeh Y. Effects of Vitex agnus and flaxseed on cyclic mastalgia: a randomized controlled trial. Complement Ther Med. 2016 Feb;25:90-5. View abstract.

Verkaik S, Kamperman AM, van Westrhenen R, Schulte PFJ. The treatment of premenstrual syndrome with preparations of vitex agnus castus: a systematic review and meta-analysis. Am J Obstet Gynecol. 2017 Aug;217(2):150-166. View abstract.

Molaie M, Darvishi B, Jafari Azar Z, Shirazi M, Amin G, Afshar S. Effects of a combination of Nigella sativa and Vitex agnus-castus with citalopram on healthy menopausal women with hot flashes: results from a subpopulation analysis. Gynecol Endocrinol. 2019 Jan;35(1):58-61. View abstract.

Csupor D, Lantos T, Hegyi P, et al. Vitex agnus-castus in premenstrual syndrome: A meta-analysis of double-blind randomised controlled trials. Complement Ther Med. 2019;47:102190. View abstract.

Naseri R, Farnia V, Yazdchi K, Alikhani M, Basanj B, Salemi S. Comparison of Vitex agnus-castus extracts with placebo in reducing menopausal symptoms: A randomized double-blind study. Korean J Fam Med. 2019;40(6):362-367. View abstract.

Ooi SL, Watts S, McClean R, Pak SC. Vitex agnus-castus for the treatment of cyclic mastalgia: A systematic review and meta-analysis. J Womens Health (Larchmt). 2020;29(2):262-278. View abstract.

Mollazadeh S, Mirghafourvand M, Abdollahi NG. The effects of Vitex agnus-castus on menstrual bleeding: A systematic review and meta-analysis. J Complement Integr Med. 2019;17(1). pii: /j/jcim.2019.17.issue-1/jcim-2018-0053/jcim-2018-0053.xml. View abstract.

Aksoy AN, Gozukara I, Kucur SK. Evaluation of the efficacy of fructus agni casti in women with severe primary dysmenorrhea: a prospective comparative Doppler study. J Obstet Gynaecol Res 2014;40(3):779-84. View abstract.

Rattanatantikul T, Maiprasert M, Sugkraroek P, Bumrungpert A. Efficacy and safety of nutraceutical on menopausal symptoms in post-menopausal women: A randomized, double-blind, placebo-controlled clinical trial. J Diet Suppl. 2020:1-15. View abstract.

Bahman M, Hajimehdipoor H, Bioos S, Hashem-Dabaghian F, Afrakhteh M, Tansaz M. Effect of Aslagh Capsule, a Traditional Compound Herbal Product on Oligomenorrhea in Patients with Polycystic Ovary Syndrome: A Three-Arm, Open-label, Randomized, Controlled Trial. Galen Med J 2019;8:e1261. View abstract.

Heirati SFD, Ozgoli G, KabodMehri R, Mojab F, Sahranavard S, Nasiri M. The 4-month effect of Vitex agnus-castus plant on sexual function of women of reproductive age: A clinical trial. J Educ Health Promot 2021;10:294. View abstract.

Soleymanzadeh F, Mahmoodi M, Shahidi S. Effect of Vitex Agnus-Castus Ethanolic Extract on Sex Hormones in Streptozotocin-Induced Diabetic Rats. J Family Reprod Health 2020;14(2):102-105. View abstract.

Najib FS, Poordast T, Mahmudi MS, Shiravani Z, Namazi N, Omrani GR. Does Vitex Agnus-Castus L. Have Deleterious Effect on Fertility and Pregnancy Outcome? An Experimental Study on Rats for Prediction of Its Safety. J Pharmacopuncture 2022;25(2):106-113. View abstract.

Tumsutti P, Maiprasert M, Sugkraroek P, Wanitphakdeedecha R, Bumrungpert A. Effects of a combination of botanical actives on skin health and antioxidant status in post-menopausal women: A randomized, double-blind, placebo-controlled clinical trial. J Cosmet Dermatol 2022;21(5):2064-2072. View abstract.

Somuncu E, Solak IHA. Colonic Obstruction Secondary to Phytobezoar Caused by Vitex Agnus-Castus Seeds: A Case Report. J Coll Physicians Surg Pak 2022;32(8):S115-S117. View abstract.

Mirzaee F, Fakari FR, Babakhanian M, Roozbeh N, Ghazanfarpour M. The Effectiveness of Herbal Medicines on Cyclic Mastalgia: A Systematic Review on Meta-analysis. Rev Bras Ginecol Obstet 2022;44(10):972-985. View abstract.

Hung NH, Quan PM, Satyal P, et al. Acetylcholinesterase Inhibitory Activities of Essential Oils from Vietnamese Traditional Medicinal Plants. Molecules 2022;27(20):7092. View abstract.

Zohreh A, Robabeh A, Peiman A, Hamid NS, Zakiyeh A. Vitagnus an estrogen-riched herbal remedy used in sexual dysfunction: A randomized clinical trial. J Educ Health Promot 2023;12:268. View abstract.